Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Your healthcare provider will also review your diabetes control, weight management goals, and any other relevant health conditions that might influence treatment decisions
Reductions in postprandial hyperglycaemia in patients with type 2 diabetes as a result of treatment with acarbose have also been shown to reduce the activity ( P = 0.045) and nuclear localisation ( P = 0.02) of the proinflammatory transcription factor NFB [59], suggesting a mechanism by which the anti-inflammatory effects of acarbose may be mediated
Freund H, Hoover HC Jr, Atamian S, et al
One of the standout advantages of sublingual medication is the bypassing of the digestive system, which can lead to quicker absorption and quicker onset of action
5
Both are short-acting and WADA-prohibited
US$ 28.79
US$ 21.77
US$ 28.03
